KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Quick Stats
55.5
AI Score
HOLD0.08
Volume Ratio
Next Earnings
18
+ve Days (30d)
11
-ve Days (30d)
KALV Stock Summary
Last updated Jan 27, 2026
KALV is currently trading at $16.19, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $8.67 to $19.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.261, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.155, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates KALV at 55.5/100 with a HOLD recommendation.
KALV (KalVista Pharmaceuticals, Inc. Common Stock) Indicators
Last updated Jan 27, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 46.261 |
| CMF (20) | -0.155 |
| ROC (10) | -8.847 |
| ADX (14) | 30.305 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.06 |
| AROONOSC (14) | -42.857 |
| WILLAMS %R (14) | -84.937 |
| MFI (14) | 41.854 |
KALV Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
KALV Price vs Max Options Open Interest
KALV Max Change In Options Open Interest
KALV Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KALV Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KALV Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KALV Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
KalVista Pharmaceuticals, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
KALV Moving Averages Analysis
KALV (KalVista Pharmaceuticals, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
KALV Fundamental Analysis
| P/E (Forward) | 19.084 |
| P/E (Trailing) | -- |
| Market Cap ($) | 782.0 million |
| Earnings/Share ($) | -3.94 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.06 |
| EPS Estimate Next Year ($) | -2.79 |
| WallStreet Target Price ($) | 33.2222 |
| Most Recent Quarter |